Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems

Journal of Comparative Neurology

Volumn 513, Issue 1, 2009, Pages 1-20

  Fetissov, Sergueï O ^a,f   Bensing, Sophie ^a   Mulder, Jan ^a   Le Maitre, Erwan ^a   Hulting, Anna Lena ^a   Harkany, Tibor ^a   Ekwall, Olov ^b,c   Sköldberg, Filip ^b   Husebye, Eystein S ^d   Perheentupa, Jaakko ^e   Rorsman, Fredrik ^b   Kämpe, Olle ^b   Hökfelt, Tomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF BERGEN   (Norway)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f Institut Fédératif de Recherches Multidisciplinaires Sur Les Peptides   (France)

Author keywords

Autoimmunity; Dopamine; Enzymes; Monoamines; Noradrenaline; Serotonin

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; AROMATIC LEVO AMINO ACID DECARBOXYLASE; AUTOANTIBODY; DOPAMINE; GLUTAMATE DECARBOXYLASE; ISOPROPAMIDE IODIDE; MONOAMINE; NORADRENALIN; SEROTONIN; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ANIMAL TISSUE; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; BRAIN TISSUE; CELL LABELING; CEREBELLAR ATAXIA; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; DOPAMINERGIC NERVE CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MONOAMINERGIC SYSTEM; MOUSE; NERVE CELL; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; STIFF MAN SYNDROME; ANIMAL; AUTOIMMUNE POLYENDOCRINOPATHY; BLOOD; BRAIN; GENETICS; HISTOLOGY; IMMUNOLOGY; METABOLISM; SERUM; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

ANIMALS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; AUTOANTIBODIES; BRAIN; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; NEUROTRANSMITTER AGENTS; POLYENDOCRINOPATHIES, AUTOIMMUNE; RATS; RATS, SPRAGUE-DAWLEY; SERUM; STIFF-PERSON SYNDROME; TRYPTOPHAN HYDROXYLASE; TYROSINE 3-MONOOXYGENASE;

EID: 59649105992     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21913     Document Type: Article

References (103)

1. Aaltonen J, Björses P, Perheentupa J, Horelli-Kuitunen N, Palotie A, Peltonen L, Lee YS, Francis F, Henning S, Thiel C, Leharach H, Yaspo M-L. 1997. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17:399-403.
2. Achenbach P, Schlosser M, Williams AJ, Yu L, Mueller PW, Bingley PJ, Bonifacio E. 2007. Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program. Clin Immunol 122:85-90.
3. Adams JC. 1992. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 40:1457-1463.
4. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. 1990. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322:1829-1836.
5. Ando-Yamamoto M, Hayashi H, Taguchi Y, Fukui H, Watanabe T, Wada H. 1986. Demonstration of immunohistochemical and immunochemical cross-reactivity of L-histidine and L-DOPA decarboxylases using antibodies against the two enzymes. Biochem Biophys Res Commun 141:306-312.
6. Baekkeskov S, Aanstoot H-J, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, Camilli P-D. 1990. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutatmic acid decarboxylase. Nature 347:151-156.
7. Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, Urban GM, Monory K, Marsicano G, Matteoli M, Canty A, Irving AJ, Katona I, Yanagawa Y, Rakic P, Lutz B, Mackie K, Harkany T. 2007. Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science 316:1212-1216.
8. Björklund A, Lindvall O. 1984. Dopamine-containing systems in the CNS. In: Björklund A, Hökfelt T, editors. Handbook of chemical neuroanatomy, vol 2. Classical transmitters in the CNS, Part I. Amsterdam: Elsevier. p 55-122.
9. Blessing WW, Costa M, Geffen LB, Rush RA, Fink G. 1977. Immune lesions of noradrenergic neurones in rat central nervous system produced by antibodies to dopamine-beta-hydroxylase. Nature 267:368-369.
10. Caillard O, Moreno H, Schwaller B, Llano I, Celio MR, Marty A. 2000. Role of the calcium-binding protein parvalbumin in short-term synaptic plasticity. Proc Natl Acad Sci U S A 97:13372-13377.
11. Christie MR, Genovese S, Cassidy D, Bosi E, Brown TJ, Lai M, Bonifacio E, Bottazzo GF. 1994. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 43:1254-1259.
12. Cocco C, Meloni A, Boi F, Pinna G, Possenti R, Mariotti S, Ferri GL. 2005. Median eminence dopaminergic nerve terminals: a novel target in autoimmune polyendocrine syndrome? J Clin Endocrinol Metab 90: 4108-4111.
13. Coons AH. 1958. Fluorescent antibody methods. In: Danielli JF, editor. General cytochemical methods. New York: Academic Press. p 399-422.
14. D'Orlando C, Celio MR, Schwaller B. 2002. Calretinin and calbindin D-28k, but not parvalbumin protect against glutamate-induced delayed excitotoxicity in transfected N18-RE 105 neuroblastoma-retina hybrid cells. Brain Res 945:181-190.
15. Dahlström A, Fuxe K. 1964. Evidence for the existence of monoamine-containing neurons in the central nervous system I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand 62(Suppl 232):1-55.
16. Dayer AG, Jenny B, Potter G, Sauvain MO, Szabo G, Vutskits L, Gascon E, Kiss JZ. 2008. Recruiting new neurons from the subventricular zone to the rat postnatal cortex: an organotypic slice culture model. Eur J Neurosci 27:1051-1060.
17. Docherty M, Bradford HF, Wu JY, Joh TH, Reis DJ. 1985. Evidence for specific immunolysis of nerve terminals using antisera against choline acetyltransferase, glutamate decarboxylase and tyrosine hydroxylase. Brain Res 339:105-113.
18. Ekwall O, Hedstrand H, Grimelius L, Haavik J, Perheentupa J, Gustafsson J, Husebye E, Kämpe O, Rorsman F. 1998. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 352:279-283.
19. Ekwall O, Sjöberg K, Mirakian R, Rorsman F, Kämpe O. 1999. Tryptophan hydroxylase autoantibodies and intestinal disease in autoimmune polyendocrine syndrome type 1. Lancet 354:568.
20. Esumi S, Wu S-X, Yanagawa Y, Obata K, Sugimoto Y, Tamamaki N. 2008. Method for single-cell microarray analysis and application to gene-expression profiling of GABAergic neuron progenitors. Neuroscience Research 60:439-451.
21. Facchini PJ, Huber-Allanach KL, Tari LW. 2000. Plant aromatic-amino acid decarboxylases: evolution, biochemistry, regulation, and metabolic engineering applications. Phytochemistry 54:121-138.
22. Falck B, Hillarp N-A, Thieme G, Torp A. 1962. Fluorescence of catecholamines and related compounds with formaldehyde. J Histochem Cytochem 10:348-354.
23. Falorni A, Grubin CE, Takei I, Shimada A, Kasuga A, Maruyama T, Ozawa Y, Kasatani T, Saruta T, Li L, et al. 1994. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 19:113-125.
24. Fetissov SO, Déchelotte P. 2008. The putative role of neuropeptide autoantibodies in anorexia nervosa. Curr Opin Clin Nutr Metab Care 11: 428-434.
25. Fetissov SO, Hallman J, Oreland L, af Klinteberg B, Grenbäck E, Hulting AL, Hökfelt T. 2002. Autoantibodies against a-MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients. Proc Natl Acad Sci U S A 99:17155-17160.
26. Fetissov SO, Harro J, Jaanisk M, Järv A, Podar I, Allik J, Nilsson I, Sakthivel P, Lefvert AK, Hökfelt T. 2005. Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proc Natl Acad Sci U S A 102:14865-14870.
27. Fetissov SO, Hallman J, Nilsson I, Lefvert AK, Oreland L, Hökfelt T. 2006. Aggressive behavior linked to corticotropin-reactive autoantibodies. Biol Psychiatry 60:799-802.
28. Fetissov SO, Hamze Sinno M, Coëffier M, Bole-Feysot C, Ducrotté P, Hökfelt T, Déchelotte P. 2008. Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora. Nutrition 24:348-359.
29. Fuxe K, Hamberger B, Hökfelt T. 1968. Distribution of noradrenaline nerve terminals in cortical areas of the rat. Brain Res 8:125-131.
30. Gebre-Medhin G, Husebye ES, Gustafsson J, Winqvist O, Goksoyr A, Rorsman F, Kämpe O. 1997. Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. FEBS Lett 412:439-445.
31. Guijarro A, Laviano A, Meguid MM. 2006. Hypothalamic integration of immune function and metabolism. Prog Brain Res 153:367-405.
32. Harkany T, Dobszay MB, Cayetanot F, Hartig W, Siegemund T, Aujard F, Mackie K. 2005. Redistribution of CB1 cannabinoid receptors during evolution of cholinergic basal forebrain territories and their cortical projection areas: a comparison between the gray mouse lemur ( Microcebus murinus, primates) and rat. Neuroscience 135:595-609.
33. Hedstrand H, Ekwall O, Haavik J, Landgren E, Betterle C, Perheentupa J, Gustafsson J, Husebye E, Rorsman F, Kämpe O. 2000. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. Biochem Biophys Res Commun 267:456-461.
34. Hökfelt T, Fuxe K. 1969. Cerebellar monoamine nerve terminals, a new type of afferent fibers to the cortex cerebelli. Exp Brain Res 9:63-72.
35. Hökfelt T, Ljungdahl Å. 1975. Uptake mechanisms as a basis for the histochemical identification of transmitter-specific neuron populations. In: Cowan M, Cuenod M, editors. The use of axonal transport for studies of neuronal connectivity. Elsevier. p 249-305.
36. Hökfelt T, Fuxe K, Goldstein M. 1973. Immunohistochemical localization of aromatic L-amino acid decarboxylase (DOPA decarboxylase) in central dopamine and 5-hydroxytryptamine nerve cell bodies of the rat. Brain Res 53:175-180.
37. Hökfelt T, Johansson O, Goldstein M. 1984a. Central catecholamine neurons as revealed by immunohistochemistry with special reference to adrenaline neurons. In: Björklund A, Hökfelt T, editors. Handbook of chemical neuroanatomy, vol 2. Classical transmitters in the CNS, Part I. Amsterdam: Elsevier. p 157-276.
38. Hökfelt T, Johansson O, Goldstein M. 1984b. Chemical anatomy of the brain. Science 225:1326-1334.
39. Hökfelt T, Mårtensson R, Björklund A, Kleinau S, Goldstein M. 1984c. Distributional maps of tyrosine hydroxylase-immunoreactive neurons in the rat brain. In: Björklund A, Hökfelt T, editors. Handbook of chemical neuroanatomy, vol 2. Classical transmitters in the CNS, Part I. Amsterdam: Elsevier. p 277-379.
40. Honnorat J, Trouillas P, Thivolet C, Aguera M, Belin MF. 1995. Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy and slow eye movement. Arch Neurol 52:462-468.
41. Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, Thivolet C, Tavolato B, Antoine JC, Trouillas P, Graus F. 2001. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 58: 225-230.
42. Huerta PT, Kowal C, DeGiorgio LA, Volpe BT, Diamond B. 2006. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A 103:678-683.
43. Husebye ES, Gebre-Medhin G, Tuomi T, Perheentupa J, Landin-Olsson M, Gustafsson J, Rorsman F, Kämpe O. 1997. Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 82:147-150.
44. Husebye ES, Bøe AS, Rorsman F, Kämpe O, Aakvaag A, Rygh T, Flatmark T, Haavik J. 2000. Inhibition of aromatic l-amino acid decarboxylase activity by human autoantibodies. Clin Exp Immunol 120:420-423.
45. Ikemoto K, Nishimura A, Oda T, Nagatsu I, Nishi K. 2003. Number of striatal D-neurons is reduced in autopsy brains of schizophrenics. Legal Medicine, Selected papers from the 5th International Symposium on Advances in Legal Medicine (ISALM) 2002 5(Suppl 1):S221-S224.
46. Jackson FR. 1990. Prokaryotic and eukaryotic pyridoxal-dependent decarboxylases are homologous. J Mol Evol 31:325-329.
47. Jaeger CB, Ruggiero DA, Albert VR, Joh TH, Reis DJ. 1984. Immunocytochemical localization of aromatic-L-aminoacid decarboxylase. In: Björklund A, Hökfelt T, editors. Handbook of chemical neuroanatomy, vol 2. Classical transmitters in the CNS, Part I. Amsterdam: Elsevier. p 387-439.
48. Jalava K, Hallanvuo S, Nakari UM, Ruutu P, Kela E, Heinasmaki T, Siitonen A, Nuorti JP. 2004. Multiple outbreaks of Yersinia pseudotuberculosis infections in Finland. J Clin Microbiol 42:2789-2791.
49. Kang UJ, Park DH, Wessel T, Baker H, Joh TH. 1992. Dopadecarboxylation in the striata of rats with unilateral substantia nigra lesions. Neurosci Lett 147:53-57.
50. Kitahama K, Ikemoto K, Jouvet A, Nagatsu I, Geffard M, Okamura H, Pearson J. 1998. Dopamine synthesizing enzymes in paraventricular hypothalamic neurons of the human and monkey (Macaca fuscata). Neurosci Lett 243:1-4.
51. Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, Diamond B. 2006. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 103:19854-19859.
52. Lang B, Dale RC, Vincent A. 2003. New autoantibody mediated disorders of the central nervous system. Curr Opin Neurol 16:351-357.
53. Leenders KL, Wolfson L, Gibbs JM, Wise RJ, Causon R, Jones T, Legg NJ. 1985. The effects of L-DOPA on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease. Brain 108(Pt 1):171-191.
54. Lernmark A. 1996. Glutamic acid decarboxylase - gene to antigen to disease. J Intern Med 240:259-277.
55. Lovas K, Loge JH, Husebye ES. 2002. Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol 56:581-588.
56. MacLeod RM, Lehmeyer JE. 1974. Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion. Endocrinology 94:1077-1085.
57. Manent JB, Jorquera I, Ben-Ari Y, Aniksztejn L, Represa A. 2006. Glutamate acting on AMPA but not NMDA receptors modulates the migration of hippocampal interneurons. J Neurosci 26:5901-5909.
58. Manto M-U, Laute M-A, Aguera M, Rogemond V, Pandolfo M, Honnorat J. 2007. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol 61:544-551.
59. Markey KA, Kondo H, Shenkman L, Goldstein M. 1980. Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line. Mol Pharmacol 17:79-85.
60. Martin-Ibanez R, Jenstad M, Berghuis P, Edwards RH, Hioki H, Kaneko T, Mulder J, Canals JM, Ernfors P, Chaudhry FA, Harkany T. 2006. Vesicular glutamate transporter 3 (VGLUT3) identifies spatially segregated excitatory terminals in the rat substantia nigra. Eur J Neurosci 23:1063-1070.
61. Mathey EK, Derfuss T, Storch MK, Williams KR, Hales K, Woolley DR, Al-Hayani A, Davies SN, Rasband MN, Olsson T, Moldenhauer A, Velhin S, Hohlfeld R, Meinl E, Linington C. 2007. Neurofascin as a novel target for autoantibodymediated axonal injury. J Exp Med 204:2363-2372.
62. Melamed E, Hefti F, Wurtman RJ. 1980. Decarboxylation of exogenous L-DOPA in rat striatum after lesions of the dopaminergic nigrostriatal neurons: the role of striatal capillaries. Brain Res 198:244-248.
63. Miller AH, Manji HK. 2006. On redefining the role of the immune system in psychiatric disease. Biol Psychiatry 60:796-798.
64. Mittaz L, Rossier C, Heino M, Peterson P, Krohn KJ, Gos A, Morris MA, Kudoh J, Shimizu N, Antonarakis SE, Scott HS. 1999. Isolation and characterization of the mouse Aire gene. Biochem Biophys Res Commun 255:483-490.
65. Moore RY, Card P. 1984. Noradrenaline-containing neuron systems. In: Björklund A, Hökfelt T, editors. Handbook of chemical neuroanatomy, vol 2. Classical transmitters in the CNS, Part I. Amsterdam: Elsevier. p 123-156.
66. Mugnaini E, Oertel WH. 1985. An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In: Björklund A, Hökfelt T, editors. Handbook of chemical neuroanatomy GABA and neuropeptides in the CNS Part I. Amsterdam: Elsevier. p 436-608.
67. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N. 1997. Positional cloning of the APECED gene. Nat Genet 17:393-398.
68. Neufeld M, Maclaren N, Blizzard R. 1980. Autoimmune polyglandular syndromes. Pediatr Ann 9:154-162.
69. Oertel WH, Tappaz ML, Berod A, Mugnaini E. 1982. Two-color immunohistochemistry for dopamine and GABA neurons in rat substantia nigra and zona incerta. Brain Res Bull 9:463-474.
70. Oldstone MB. 1998. Molecular mimicry and immune-mediated diseases. FASEB J 12:1255-1265.
71. Ottersen OP, Storm-Mathisen J. 1984. Glutamate- and GABA-containing neurons in the mouse and rat brain, as demonstrated with a new immunocytochemical technique. J Comp Neurol 229:374-392.
72. Pearce DA, Atkinson M, Tagle DA. 2004. Glutamic acid decarboxylase autoimmunity in Batten disease and other disorders. Neurology 63: 2001-2005.
73. Pease PC. 1962. Buffered formaldehyde as a killing agent and primary fixative for electron microscopy. Anat Rec 142:342.
74. Peterson P, Uibo R, Krohn KJ. 2000. Adrenal autoimmunity: results and developments. Trends Endocrinol Metab 11:285-290.
75. Pittock SJ, Yoshikawa H, Ahlskog JE, Tisch SH, Benarroch EE, Kryzer TJ, Lennon VA. 2006. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc 81:1207-1214.
76. Rautemaa R, Richardson M, Pfaller M, Koukila-Kahkola P, Perheentupa J, Saxen H. 2007. Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. J Antimicrob Chemother 60:889-892.
77. Rommelfanger KS, Weinshenker D, Miller GW. 2004. Reduced MPTP toxicity in noradrenaline transporter knockout mice. J Neurochem 91:1116-1124.
78. Rorsman F, Husebye ES, Winqvist O, Björk E, Karlsson FA, Kämpe O. 1995. Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen. Proc Natl Acad Sci U S A 92:8626-8629.
79. Sakumoto T, Sakai K, Jouvet M, Kimura H, Maeda T. 1984. 5-HT immunoreactive hypothalamic neurons in rat and cat after 5-HTP administration. Brain Res Bull 12:721-733.
80. Schnell SA, Staines WA, Wessendorf MW. 1999. Reduction of lipofuscinlike autofluorescence in fluorescently labeled tissue. J Histochem Cytochem 47:719-730.
81. Schwaller B, Meyer M, Schiffmann S. 2002. 'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice. Cerebellum 1:241-258.
82. Singec I, Knoth R, Ditter M, Volk B, Frotscher M. 2004. Neurogranin is expressed by principal cells but not interneurons in the rodent and monkey neocortex and hippocampus. J Comp Neurol 479:30-42.
83. Söderbergh A, Rorsman F, Halonen M, Ekwall O, Björses P, Kämpe O, Husebye ES. 2000. Autoantibodies against aromatic L-amino acid decarboxylase identifies a subgroup of patients with Addison's disease. J Clin Endocrinol Metab 85:460-463.
84. Söderbergh A, Myhre AG, Ekwall O, Gebre-Medhin G, Hedstrand H, Landgren E, Miettinen A, Eskelin P, Halonen M, Tuomi T, Gustafsson J, Husebye ES, Perheentupa J, Gylling M, Manns MP, Rorsman F, Kämpe O, Nilsson T. 2004. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 89:557-562.
85. Solimena M, De Camilli P. 1991. Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci 14:452-457.
86. Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P, Vicari AM. 1988. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 318:1012-1020.
87. Stanić D, Brumovsky P, Fetissov SO, Shuster S, Herzog H, Hökfelt T. 2006. Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals. J Comp Neurol 499:357-390.
88. Steinbusch HWM. 1984. Serotonin-immunoreactive neurons and their projections in the CNS. In: Björklund A, Hökfelt T, editors. Handbook of chemical neuroanatomy, vol 3. Classical transmitters and transmitter receptors in the CNS, Part II. Amsterdam: Elsevier. p 68-125.
89. Steinbusch HWM, Mulder AH. 1984. Immunohistochemical localization of histamine in neurons and mast cells in the rat brain. In: Björklund A, Hökfelt T, editors. Handbook of chemical neuroanatomy, vol 3. Classical transmitters and transmitter receptors in the CNS, Part II. Amsterdam: Elsevier. p 126-140.
90. Steinbusch HWM, Verhofstad AAJ, Joosten HWJ. 1983. Antibodies to serotonin for neuroimmunocytochemical studies on the central nervous system. Methodological aspects and applications. In: Cuello AC, editor. Neuroimmunocytochemistry, IBRO handbook series: methods in the neurosciences. Chichester, UK: John Wiley & Sons. p 193-214.
91. Steinman L. 2004. Elaborate interactions between the immune and nervous systems. Nat Immunol 5:575-581.
92. Taguchi Y, Watanabe T, Shiosaka S, Tohyama M, Wada H. 1985. Immunohistochemical analysis of the cross-reaction of anti-rat histidine decarboxylase antibody with guinea-pig DOPA decarboxylase. Brain Res 340:235-242.
93. Tamamaki N, Yanagawa Y, Tomioka R, Miyazaki J, Obata K, Kaneko T. 2003. Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J Comp Neurol 467:60-79.
94. Tanaka DH, Maekawa K, Yanagawa Y, Obata K, Murakami F. 2006. Multidirectional and multizonal tangential migration of GABAergic interneurons in the developing cerebral cortex. Development 133:2167-2176.
95. Tison F, Normand E, Jaber M, Aubert I, Bloch B. 1991. Aromatic L-aminoacid decarboxylase (DOPA decarboxylase) gene expression in dopaminergic and serotoninergic cells of the rat brainstem. Neurosci Lett 127:203-206.
96. Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A. 1996. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 81:1488-1494.
97. Ugrumov MV, Melnikova VI, Lavrentyeva AV, Kudrin VS, Rayevsky KS. 2004. Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal rats. Neuroscience 124:629-635.
98. Vianello M, Keir G, Giometto B, Betterle C, Tavolato 8, Thompson EJ. 2005. Antigenic differences between neurological and diabetic patients with anti-glutarnic acid decarboxylase antibodies. Eur J Neurol 12: 294-299.
99. Watanabe T, Taguchi Y, Hayashi H, Tanaka J, Shiosaka J, Tohyama M, Kubota H, Terano Y, Wada H. 1983. Evidence for the presence of a histaminergic neuron system in the rat brain: an immunohistochemical analysis. Neurosci Lett 39:249-254.
100. Wincivist O, Karlsson FA, Kämpe O. 1992. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 339:1559-1562.
101. Wong CG; Bottigheri T, Snead OCr. 2003. GABA, gamma-hydroxybutyric acid, and neurological disease. Ann Neurol 54:S3-S12.
102. Zamboni L, De Martino C. 1967. Buffered picric acid formaldehyde: a new rapid fixative for electron microscopy. J Cell Biol 35:148A.
103. Ziegler MG, Thomas JA, Jacobowitz DM. 1976. Retrograde axonal transport of antibody to-dopamine-beta-hydroxtylase. Brain Res 104:390-395.